The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 71 | 0.8x | 20.1x | Above average | |
Growth | 85 | 14.5% | 5.6% | Above average | |
Quality | 76 | 309.4% | 7.6% | Above average | |
Safety | 31 | 37.5x | 0.4x | Below average | |
Capital Return | 93 | — | 2.19% | Above average | |
Momentum | 40 | — | — | Near average | |
Sentiment | 2 | — | — | Below average |
Fortress Biotech, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Fortress Biotech, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Fortress Biotech stock shows complete stability in its target price at 5 dollars over the last 30 days, with zero Dispersion among analysts due to only one analyst currently covering the stock in the updated data. This stability reflects theoretical optimism with a positive price gap compared to the current price (2.74 dollars), but simultaneously indicates a decrease in the depth of analytical coverage for the stock.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.